Omicia

UNLOCKING INDIVIDUALIZED MEDICINE

We help researchers and clinicians understand, interpret and report on genome sequence data.

Research

Annotate genomes with Omicia’s fast and accurate annotation pipeline, then use filters and advanced analyses to identify and prioritize disease-causing variants.

Learn More >>

Clinical

Omicia Clinical provides standardized workflows and physician-ready reports, allowing you to leverage the power of Opal in a diagnostic setting.

Learn More >>

Clinical Trials

Use whole genome analysis to identify patients whose genotype fits your target profile. Analyze clinical trial cohorts to identify shared genetic variants, or segment participants based on genetic profile.

Learn More >>

Our Customers

Omicia continues to lead the genome analysis field by partnering with world-renowned institutions. Their invaluable contributions and feedback keep Omicia at the forefront of clinical genome interpretation.

aruplabs
cornell
ecolepoly
uofvienna
uofutah
uofmiami
ucsc
osaka
mahidol
mountsinai
kiel
johnhopkins
ucsf
craig-venter
ngi
coldspring

NEWS

March 18, 2014
Omicia Co-founder & President, Martin Reese, Speaks to Mendelspod about Scaling Up Clinical Interpretation of the Human Genome
Watch the interview
March 18, 2014
From DNA to Diagnosis: Integrating Genome Data into Patient Care
Read more
January 8, 2014
Omicia Hopes to Boil Down Genomic Big Data into More Useful Information, Raises $6.8M
Read more

Get Started Now

Omicia enables researchers and clinicians to analyze genomes and prioritize disease-causing variants and genes, reducing the noise and pinpointing clinically relevant findings.